Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions

  • Authors:
    • Benjamin Atchie
    • Stephanie Jarvis
    • Richard Bellon
    • Trevor Barton
    • Lauren Disalvo
    • Kristin Salottolo
    • Raphael Bar-Or
    • David Bar-Or
  • View Affiliations / Copyright

    Affiliations: Department of Neuroradiology, Swedish Medical Center, Injury Outcomes Network (ION) Research, Englewood, CO 80113, USA, Department of Epidemiology, Injury Outcomes Network (ION) Research, Englewood, CO 80113, USA, Department of Neurology, Swedish Medical Center, Injury Outcomes Network (ION) Research, Englewood, CO 80113, USA, Department of Basic Science, Injury Outcomes Network (ION) Research, Englewood, CO 80113, USA, Department of Directors, Injury Outcomes Network (ION) Research, Englewood, CO 80113, USA
    Copyright: © Atchie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 295
    |
    Published online on: May 5, 2023
       https://doi.org/10.3892/etm.2023.11994
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Collateral circulation is important for cerebral perfusion in acute ischemic strokes. Monitoring the oxidation‑reduction potential (ORP) may be useful to assess collateral status or treatment efficacy. The objectives of the present study were to determine if the ORP was associated with collateral circulation status in middle cerebral artery (MCA) occlusions and to identify patterns in the ORP and the collateral circulation status among patients treated with intraarterial therapy (IAT) over time. The present pilot study was nested within a prospective cohort study measuring the ORP of the peripheral venous plasma of stroke patients. The population included in the present study were patients with MCA (M1/M2) occlusions. Two ORP parameters were examined: Static ORP (sORP; mV), indicating oxidative stress, and capacity ORP (cORP; µC), indicating antioxidant reserves. Collateral status was retrospectively graded using Miteff's system as good (grade 1) or reduced (grade 2/3). Comparisons were made between collateral status groups (reduced vs. good collaterals) in all patients, within a subset including only patients who received IAT, and between thrombolysis in cerebral infraction scale score (TICI) groups (0‑2a vs. 2b/3). The Fisher's exact test, Student's t‑test and Wilcoxon tests were used (α<0.20). The 19 patients were categorized based on their collaterals: Good collaterals (53%) and reduced collaterals (47%). The baseline characteristics were similar with the exception that the patients with good collaterals had a lower international normalized ratio (P=0.12) and were more likely to have a stroke on the left side (P=0.18) or to have a mismatch (P=0.05). The admission sORP values were comparable (169.5 vs. 164.2 mV; P=0.65), as was admission cORP (P=0.73). When considering only the patients who received IAT (n=12), admission sORP (P=0.69) and cORP (P=0.90) were also statistically similar. On day 2, after IAT, both groups experienced a worsening in ORP measures; however, the patients with good collaterals had a significantly lower sORP (169.4 vs. 203.5 mV; P=0.02) and a higher cORP (0.2 vs. 0.1 µC; P=0.002) compared with the patients with reduced collaterals. Neither sORP nor cORP were significantly different between TICI score groups on admission or on day 2. Upon discharge, patients with a TICI of 2b‑3 had a significantly better sORP (P=0.03) and cORP (P=0.12) compared with those with a TICI of 0‑2a. In conclusion, upon patient admission, the ORP parameters were not significantly different between the collateral circulation status groups for MCA occlusions. The ORP parameters worsened after IAT regardless of the collateral circulation status; however, after IAT, on day 2, patients with good collaterals experienced less oxidative stress (sORP) and had higher antioxidant reserves (cORP) than patients with reduced collaterals.
View Figures
View References

1 

Liebeskind DS: Collateral Circulation. Stroke. 34:2279–2284. 2003.PubMed/NCBI View Article : Google Scholar

2 

Menon BK, Qazi E, Nambiar V, Foster LD, Yeatts SD, Liebeskind D, Jovin TG, Goyal M, Hill MD, Tomsick TA, et al: Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III trial. Stroke. 46:1239–1244. 2015.PubMed/NCBI View Article : Google Scholar

3 

Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, Kim D, Jahan R, Duckwiler GR, Yoon SR, et al: Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 79:625–629. 2008.PubMed/NCBI View Article : Google Scholar

4 

Demirbag R, Gur M, Yilmaz R, Kunt AS, Erel O and Andac MH: Influence of oxidative stress on the development of collateral circulation in total coronary occlusions. Int J Cardiol. 116:14–19. 2007.PubMed/NCBI View Article : Google Scholar

5 

Bjugstad KB, Rael LT, Levy S, Carrick M, Mains CW, Slone DS and Bar-Or D: Oxidation-Reduction Potential as a Biomarker for Severity and Acute Outcome in Traumatic Brain Injury. Oxid Med Cell Longev. 2016(6974257)2016.PubMed/NCBI View Article : Google Scholar

6 

Chen Z and Zhong C: Oxidative stress in Alzheimer's disease. Neurosci Bull. 30:271–281. 2014.PubMed/NCBI View Article : Google Scholar

7 

Rael LT, Bar-Or R, Kelly MT, Carrick MM and Bar-Or D: Assessment of oxidative stress in patients with an isolated traumatic brain injury using disposable electrochemical test strips. Electroanalysis. 27:2567–2573. 2015.

8 

Spanidis Y, Mpesios A, Stagos D, Goutzourelas N, Bar-Or D, Karapetsa M, Zakynthinos E, Spandidos DA, Tsatsakis AM, Leon G and Kouretas D: Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations. Exp Ther Med. 11:895–903. 2016.PubMed/NCBI View Article : Google Scholar

9 

Sinha N and Dabla PK: Oxidative Stress and Antioxidants in Hypertension-A Current Review. Curr Hypertens Rev. 11:132–142. 2015.PubMed/NCBI View Article : Google Scholar

10 

Bourg P, Salottolo K, Klein J and Bar-Or D: Can a biomarker for oxidative stress and antioxidant reserves identify frailty in geriatric trauma patients? Injury. 52:2908–2913. 2021.PubMed/NCBI View Article : Google Scholar

11 

Kirkham PA and Barnes PJ: Oxidative stress in COPD. Chest. 144:266–273. 2013.PubMed/NCBI View Article : Google Scholar

12 

Salottolo KM, Fanale CV, Leonard KA, Frei DF and Bar-Or D: Multimodal imaging does not delay intravenous thrombolytic therapy in acute stroke. AJNR Am J Neuroradiol. 32:864–868. 2011.PubMed/NCBI View Article : Google Scholar

13 

Bjugstad KB, Fanale C, Wagner J, Jensen J, Salottolo K, Rael LT and Bar-Or D: A 24 h Delay in the Redox Response Distinguishes the most Severe Stroke Patients from Less Severe Stroke Patients. J Neurol Neurophysiol. 07(395)2016.

14 

Rael LT, Leonard J, Salottolo K, Bar-Or R, Bartt RE, Wagner JC and Bar-Or D: Plasma oxidized albumin in acute ischemic stroke is associated with better outcomes. Front Neurol. 10(709)2019.PubMed/NCBI View Article : Google Scholar

15 

Wagner JC, Salottolo K, Fanale CV, Whaley M, McCarthy KL and Bar-Or D: Abstract T P219: A Novel Method for Measuring Oxidative Stress in Patients with Stroke Symptoms. Stroke 46 Suppl. 1(ATP219)2015.

16 

Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P and Parsons MW: The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain. 132(Pt 8):2231–2238. 2009.PubMed/NCBI View Article : Google Scholar

17 

Seker F, Potreck A, Möhlenbruch M, Bendszus M and Pham M: Comparison of four different collateral scores in acute ischemic stroke by CT angiography. J Neurointerv Surg. 8:1116–1118. 2016.PubMed/NCBI View Article : Google Scholar

18 

Bar-Or D, Bar-Or R, Rael LT and Brody EN: Oxidative stress in severe acute illness. Redox Biol. 4:340–345. 2015.PubMed/NCBI View Article : Google Scholar

19 

National Institutes of Health and National Institutes of Neurological Disorders and Stroke. NIH Stroke Scale. 1-5. https://www.stroke.nih.gov/resources/scale.htm. Accessed 3/28/2023.

20 

Joint Commission National Quality Measures: Modified Rankin Score (mRS) Specifications Manual. 1-3. 2023. https://manual.jointcommission.org/releases/TJC2023B/DataElem0773.html. Accessed 3/28/2023.

21 

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, et al: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 34:e109–e137. 2003.PubMed/NCBI View Article : Google Scholar

22 

Lewis M, Bromley K, Sutton CJ, McCray G, Myers HL and Lancaster GA: Determining sample size for progression criteria for pragmatic pilot RCTs: The hypothesis test strikes back! Pilot Feasibility. Stud. 7(40)2021.PubMed/NCBI View Article : Google Scholar

23 

Schoenfeld D: Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys. 6:371–374. 1980.PubMed/NCBI View Article : Google Scholar

24 

Kianifard F and Islam MZ: A guide to the design and analysis of small clinical studies. Pharm Stat. 10:363–368. 2011.PubMed/NCBI View Article : Google Scholar

25 

Stallard N: Optimal sample sizes for phase II clinical trials and pilot studies. Stat Med. 31:1031–1042. 2012.PubMed/NCBI View Article : Google Scholar

26 

Gómez-de-Mariscal E, Guerrero V, Sneider A, Jayatilaka H, Phillip JM, Wirtz D and Muñoz-Barrutia A: Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets. Sci Rep. 11(20942)2021.PubMed/NCBI View Article : Google Scholar

27 

Boers AM, Jansen IG, Berkhemer OA, Yoo AJ, Lingsma HF, Slump CH, Roos YB, van Oostenbrugge RJ, Dippel DW, van der Lugt A, et al: Collateral status and tissue outcome after intra-arterial therapy for patients with acute ischemic stroke. J Cereb Blood Flow Metab. 37:3589–3598. 2017.PubMed/NCBI View Article : Google Scholar

28 

Sarraj A, Goyal N, Chen M, Grotta JC, Blackburn S, Requena M, Kamal H, Abraham MG, Elijovich L, Dannenbaum M, et al: Direct to angiography vs repeated imaging approachs in transferred patients undergoing endovascular thrombectomy. JAMA Neurol. 78:916–926. 2021.PubMed/NCBI View Article : Google Scholar

29 

Yazici S, Demirtas S, Guclu O, Karahan O, Yavuz C, Caliskan A and Mavitas B: Using oxidant and antioxidant levels to predict the duration of both acute peripheral and mesenteric ischemia. Perfusion. 29:450–455. 2014.PubMed/NCBI View Article : Google Scholar

30 

Semerano A, Laredo C, Zhao Y, Rudilosso S, Renú A, Llull L, Amaro S, Obach V, Planas AM, Urra X and Chamorro Á: Leukocytes, collateral circulation, and reperfusion in ischemic stroke patients treated with mechanical thrombectomy. Stroke. 50:3456–3464. 2019.PubMed/NCBI View Article : Google Scholar

31 

Tang Z, Zhu Y, Lu X, Wu D, Fan X, Shen J and Xiao L: Deep learning-based prediction of hematoma expansion using a single brain computed tomographic slice in patients with spontaneous intracerebral hemorrhages. World Neurosurg. 165:e128–e136. 2022.PubMed/NCBI View Article : Google Scholar

32 

Tang ZR, Chen Y, Hu R and Wang H: Predicting hematoma expansion in intracerebral hemorrhage from brain CT scans via K-nearest neighbors matting and deep residual network. Biomed Signal Process Control. 76(103656)2022.

33 

Wufuer A, Wubuli A, Mijiti P, Zhou J, Tuerxun S, Cai J, Ma J and Zhang X: Impact of collateral circulation status on favorable outcomes in thrombolysis treatment: A systematic review and meta-analysis. Exp Ther Med. 15:707–718. 2018.PubMed/NCBI View Article : Google Scholar

34 

Marks MP, Lansberg MG, Mlynash M, Olivot JM, Straka M, Kemp S, McTaggart R, Inoue M, Zaharchuk G, Bammer R, et al: Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke. Stroke. 45:1035–1039. 2014.PubMed/NCBI View Article : Google Scholar

35 

Liebeskind DS, Jahan R, Rogueira RG, Zaidat OO and Saver JL: SWIFT Investigators. Impact of collaterals on successful revascularization in solitaire FR with the intention for thrombectomy. Stroke. 45:2036–2040. 2014.PubMed/NCBI View Article : Google Scholar

36 

Tan BL, Norhaizan ME and Liew WP: Nutrients and oxidative stress: Friend or foe? Oxid Med Cell Longev. 2018(9719584)2018.PubMed/NCBI View Article : Google Scholar

37 

Loh KP, Qi J, Tan BK, Liu XH, Wei BG and Zhu YZ: Leonurine protects middle cerebral artery occluded rats through antioxidant effect and regulation of mitochondrial function. Stroke. 41:2661–2668. 2010.PubMed/NCBI View Article : Google Scholar

38 

Liu ZJ, Ran YY, Qie SY, Gong WJ, Gao FH, Ding ZT and Xi JN: Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci Ther. 25:1353–1362. 2019.PubMed/NCBI View Article : Google Scholar

39 

Chang CY, Chen JY, Wu MH and Hu ML: Therapeutic treatment with vitamin C reduces focal cerebral ischemia-induced brain infarction in rats by attenuating disruptions of blood brain barrier and cerebral neuronal apoptosis. Free Radic Biol Med. 155:29–36. 2020.PubMed/NCBI View Article : Google Scholar

40 

Mota M, Porrini V, Parrella E, Benarese M, Bellucci A, Rhein S, Schwaninger M and Pizzi M: Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia. J Neuroinflammation. 17(361)2020.PubMed/NCBI View Article : Google Scholar

41 

Liu Q, Jin Z, Xu Z, Yang H, Li L, Li G, Li F, Gu S, Zong S, Zhou J, et al: Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. Cell Stress Chaperones. 24:441–452. 2019.PubMed/NCBI View Article : Google Scholar

42 

Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin M, Ma X, Zhou K, Qi J, Yu B and Kou J: Ruscogenin attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Int J Mol Sci. 17(1418)2016.PubMed/NCBI View Article : Google Scholar

43 

Bahonar A, Saadatnia M, Khorvash F, Maracy M and Khosravi A: Carotenoids as potential antioxidant agents in stroke prevention: A systematic review. Int J Prev Med. 8(70)2017.PubMed/NCBI View Article : Google Scholar

44 

Törnwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Albanes D and Huttunen JK: Postintervention effect of alpha tocopherol and beta carotene on different strokes: A 6-year follow-up of the alpha tocopherol, beta carotene cancer prevention study. Stroke. 35:1908–1913. 2004.PubMed/NCBI View Article : Google Scholar

45 

Rabadi MH and Kristal BS: Effect of vitamin C supplementation on stroke recovery: A case-control study. Clin Interv Aging. 2:147–151. 2007.PubMed/NCBI View Article : Google Scholar

46 

Suter PM: Effect of Vitamin E, Vitamin C, and beta-carotene on stroke risk. Nutr Rev. 58:184–187. 2000.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Atchie B, Jarvis S, Bellon R, Barton T, Disalvo L, Salottolo K, Bar-Or R and Bar-Or D: Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions. Exp Ther Med 25: 295, 2023.
APA
Atchie, B., Jarvis, S., Bellon, R., Barton, T., Disalvo, L., Salottolo, K. ... Bar-Or, D. (2023). Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions. Experimental and Therapeutic Medicine, 25, 295. https://doi.org/10.3892/etm.2023.11994
MLA
Atchie, B., Jarvis, S., Bellon, R., Barton, T., Disalvo, L., Salottolo, K., Bar-Or, R., Bar-Or, D."Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions". Experimental and Therapeutic Medicine 25.6 (2023): 295.
Chicago
Atchie, B., Jarvis, S., Bellon, R., Barton, T., Disalvo, L., Salottolo, K., Bar-Or, R., Bar-Or, D."Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions". Experimental and Therapeutic Medicine 25, no. 6 (2023): 295. https://doi.org/10.3892/etm.2023.11994
Copy and paste a formatted citation
x
Spandidos Publications style
Atchie B, Jarvis S, Bellon R, Barton T, Disalvo L, Salottolo K, Bar-Or R and Bar-Or D: Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions. Exp Ther Med 25: 295, 2023.
APA
Atchie, B., Jarvis, S., Bellon, R., Barton, T., Disalvo, L., Salottolo, K. ... Bar-Or, D. (2023). Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions. Experimental and Therapeutic Medicine, 25, 295. https://doi.org/10.3892/etm.2023.11994
MLA
Atchie, B., Jarvis, S., Bellon, R., Barton, T., Disalvo, L., Salottolo, K., Bar-Or, R., Bar-Or, D."Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions". Experimental and Therapeutic Medicine 25.6 (2023): 295.
Chicago
Atchie, B., Jarvis, S., Bellon, R., Barton, T., Disalvo, L., Salottolo, K., Bar-Or, R., Bar-Or, D."Oxidation‑reduction potential parameters worsen following intraarterial therapy in patients with reduced collateral circulation and middle cerebral artery occlusions". Experimental and Therapeutic Medicine 25, no. 6 (2023): 295. https://doi.org/10.3892/etm.2023.11994
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team